GJGeorge Tharayil John

George Tharayil John

*This is an algorithmically generated author record based on publicly available information.

George Tharayil John has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    What do we know about chronic kidney disease in India: first report of the Indian CKD registry

    by Mohan M Rajapurkar, George T John, Ashok L Kirpalani, Georgi Abraham, Sanjay K Agarwal, Alan F Almeida, Sishir Gang, Amit Gupta, Gopesh Modi, Dilip Pahari, et al.

    Background: There are no national data on the magnitude and pattern of chronic kidney disease (CKD) in India. The Indian CKD Registry documents the demographics, etiological spectrum, practice patterns, variations and special characteristics. Methods: Data was collected for this cross-sectional study in a standardized format according to predetermined criteria. Of the 52,273 adult patients, 35.5%, 27.9%, 25.6% and 11% patients came from South, North, West and East zones respectively. Results: The mean age was 50.1 ± 14.6 years, with M:F ratio of 70:30. Patients from North Zone were younger and those from the East Zone older. Diabetic nephropathy was the commonest cause (31%), followed by CKD of undetermined etiology (16%), chronic glomerulonephritis (14%) and hypertensive nephrosclerosis (13%). About 48% cases presented in Stage V; they were younger than those in Stages III-IV. Diabetic nephropathy patients were older, more likely to present in earlier stages of CKD and had a higher frequency of males; whereas those with CKD of unexplained etiology were younger, had more females and more frequently presented in Stage V. Patients in lower income groups had more advanced CKD at presentation. Patients presenting to public sector hospitals were poorer, younger, and more frequently had CKD of unknown etiology. Conclusions: This report confirms the emergence of diabetic nephropathy as the pre-eminent cause in India. Patients with CKD of unknown etiology are younger, poorer and more likely to present with advanced CKD. There were some geographic variations.


  • Open Access

    Cryptococcal granulomatous interstitial nephritis and dissemination in a patient with untreated lupus nephritis

    by Vinoi George David, Anila Korula, Lisa Choudhrie, Joy Sarojini Michael, Shibu Jacob, Chakko Korula Jacob, George T. John

    Infection is a significant cause of mortality and morbidity in systemic lupus erythematosus (SLE). There are many reports of cryptococcal infection in patients with SLE, on immunosuppression. However, untreated lupus with cryptococcal infection and dissemination is rare. CD4 lymphopaenia is not reported in such patients. We describe a patient with untreated SLE to be having cryptococcal granulomatous interstitial nephritis and dissemination with CD4 lymphopaenia.


  • Placement of a Catheter through the Struts of a Previously Placed Stent for Maintenance Hemodialysis: A Case Report

    by Rajesh Joseph, Shyamkumar N. Keshava, R. S. Surendrababu Narayanam, George T. John

    Venous accesses for hemodialysis are beset with thrombosis and stenosis, often resulting in loss of central venous access. We report a case in which an alternate access was created by placement of hemodialysis catheter into the central vasculature by penetrating a stent previously placed in the stenosed right brachio-cephalic vein. To our knowledge, this is the first such report.


  • Open Access

    A limited sampling strategy for tacrolimus in renal transplant patients

    by Binu S. Mathew, Denise H. Fleming, Visalakshi Jeyaseelan, Sujith J. Chandy, V. M. Annapandian, P. K. Subbanna, George T. John

    WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Tacrolimus trough concentration is being currently used for dose individualization.• Limited sampling strategies (LSS) have been developed and validated for renal transplant patients.• Earlier literature has suggested that measurement of tacrolimus AUC is more reliable than trough with respect to both rejection and nephrotoxicity. WHAT THIS STUDY ADDS • Four thousand renal transplants take place annually in India, with many patients prescribed tacrolimus in combination with mycophenolate and steroid.• In this study a LSS with two points, i.e. trough and 1.5 h postdose was developed and validated to estimate AUC0–12.• The added benefit of only a single additional sample with completion of blood collection in 1.5 h and minimum additional cost makes this a viable LSS algorithm in renal transplant patients.• In patients having tacrolimus trough concentrations outside the recommended range (10 ng ml−1 in the treatment protocol in our institution) or having side‐effects in spite of trough concentrations in the desired range, we can estimate AUC using this LSS for a better prediction of exposure.AIMS: To develop and validate limited sampling strategy (LSS) equations to estimate area under the curve (AUC0–12) in renal transplant patients.METHODS: Twenty‐nine renal transplant patients (3–6 months post transplant) who were at steady state with respect to tacrolimus kinetics were included in this study. The blood samples starting with the predose (trough) and collected at fixed time points for 12 h were analysed by microparticle enzyme immunoassay. Linear regression analysis estimated the correlations of tacrolimus concentrations at different sampling time points with the total measured AUC0–12. By applying multiple stepwise linear regression analysis, LSS equations with acceptable correlation coefficients (R2), bias and precision were identified. The predictive performance of these models was validated by the jackknife technique.RESULTS: Three models were identified, all with R2 ≥ 0.907. Two point models included one with trough (C0) and 1.5 h postdose (C1.5), another with trough and 4 h postdose. Increasing the number of sampling time points to more than two increased R2 marginally (0.951 to 0.990). After jackknife validation, the two sampling time point (trough and 1.5 h postdose) model accurately predicted AUC0–12. Regression coefficient R2 = 0.951, intraclass correlation = 0.976, bias [95% confidence interval (CI)] 0.53% (−2.63, 3.69) and precision (95% CI) 6.35% (4.36, 8.35).CONCLUSION: The two‐point LSS equation [AUC0–12 = 19.16 + (6.75.C0) + (3.33.C1.5)] can be used as a predictable and accurate measure of AUC0–12 in stable renal transplant patients prescribed prednisolone and mycophenolate.


  • A Model for Human Leukocyte Antigen–Matched Donor-Swap Transplantation in India

    by Gopal Basu, Dolly Daniel, Arunachalam Rajagopal, Nithya Neelakantan, George T. John

    Background. In developing countries such as India, extending donor-swap transplantation (DSTx) to human leukocyte antigen (HLA)-mismatched patient-donor pairs would increase well-matched living donor kidney transplantation rates, resulting in use of less immunosuppression and less expenses, lower infective morbidity, and better survival. A model for DSTx based on HLA matching is presented. Methods. Consecutive HLA class 1 antigen (A, B) tests of prospective renal allograft recipients and their related donors, performed at a single center in India was analyzed retrospectively using an HLA matching program to determine the proportion of prospective recipients with poorly matched related donors who could have benefited by DSTx based on HLA matching. Results. Over the past 17.5 years, 2,129 prospective renal allograft recipients and 2,890 donors were tested for HLA class I (A and B) antigens. Of the prospective recipients, 33% did not have well-matched donors (defined as blood group compatible and sharing ≥2 of 4 HLA class I antigens). Among such recipients, 19.2% could have found a well-matched donor-swap pair within a year at a single center. This number would increase to 38% if four major national centers were involved with a shared HLA registry. Conclusions. Nearly 40% of prospective recipients without well-matched donors would find a donor-swap pair based on HLA matching within a year, with coordination among four national centers and a shared HLA registry, increasing the well-matched living donor renal transplant rates and improving transplant outcomes. This finding is relevant in the context of Indian government amending the Transplantation of Human Organs Act to encourage DSTx.


  • Pediatric renal transplantation – A single center experience of 15 yr from India

    by Bobby Chacko, Timothy Rajamanickam, Nithya Neelakantan, V. Tamilarasi, George T. John

    Abstract:  Renal transplantation is the optimal treatment for children with ESRD. We undertook this study to establish the outcome of pediatric renal transplants in a resource‐constrained environment in a developing country. A retrospective analysis on 90 pediatric renal transplants (age at transplant ≤18 yr) done at our center over a 15 yr period was analyzed. The mean age of the recipients was 15 yr (range 6–18 yr) accounting for 6.1% of all the renal transplants done at our center (90/1472). Ninety‐six percent of patients received kidneys from live‐related donors. The major causes of ESRD were glomerulonephritis (28%) and urological abnormalities (17%), while the etiology was unknown in 50%. Immunosuppression was based on a triple drug regimen consisting of prednisolone, CsA and azathioprine in 98% of children. Amongst complications, any acute rejection episodes (46.7%), UTI (26.7%) and CMV disease (16.7%) predominated. The mean duration of follow‐up was 42 ± 33 month (range 3–159 month). Graft loss occurred in nine (10%) children at a mean duration of 25 ± 22 month (range 6–70 month). Overall 1‐, 5‐, and 10‐yr graft survival was 98%, 84% and 76%. Overall 1‐, 5‐, and 10‐yr patient survival was 95%, 87%, and 79%. The significant predictors of graft loss were CMV disease (p = 0.018) and >2 rejection episodes (p = 0.05), while sepsis (p = 0.01) was the most important contributor to patient loss. Pediatric renal transplantation in India can be accomplished successfully. The graft and patient survival in our study, the largest from India, is comparable to those published from developed countries and is encouraging given the limited resources.


    • 1 July 2007
      • Vol. 50  (3) , 482-4

    Infections with atypical mycobacteria in renal transplant recipients.

    by Suceena Alexander, George T John, Mary Jesudason, C K Jacob

    Infections due to atypical mycobacteria are infrequent in renal transplant recipients but they cause serious morbidity. These pathogens are common in patients with acquired immune deficiency syndrome (AIDS). We report four proven cases of infections caused with atypical mycobacteriae from 1997 to 2003, by different organisms namely, M. chelonei, M.fortuitum, M. abcessus and M. terrae in renal transplant recipients. Infection with M. terrae documented here is the first occurrence in a renal transplant patient. Histopathological examination of aspirates or biopsy specimens from involved areas and staining and culture for mycobacteriae are essential for diagnosis. Treatment involves antimycobacterial therapy, reduction in immunosuppression and surgery, if indicated. Atypical mycobacterial infections, though currently uncommon, are significant and could prove to be an emerging pathogen in renal transplant recipients in the context of the AIDS epidemic in India.


  • Pulmonary Mucormycosis in a Nondiabetic Renal Allograft Recipient Successfully Managed by Medical Therapy Alone

    by Bobby Chacko, Vinoi George David, Veeraswamy Tamilarasi, Akkihebbal N. Deepti, George T. John


    • 1 August 2006
      • Vol. 124  (2) , 185-8

    Prevalence of proteinuria in rural adult population in Tamil Nadu.

    by Isthiaque Ahmed, George T John, Meshach G Kirubakaran, Chakko K Jacob, Jayaprakash Muliyil

    Presence of proteinuria is considered as an early marker of an increased risk of progressive kidney disease. Angiotensin converting enzyme (ACE) inhibitors (ACEi) and angiotensin II receptor blockers (ARB) treatment to persons with proteinuria and chronic kidney disease has been shown to decrease the progression to endstage renal disease. As the exact prevalence of proteinuria is not known in the general population, we undertook this study to estimate the same in a rural adult population in Vellore district, Tamil Nadu. A convenient sample of 5,043 adults was included. All individuals were tested for albuminuria by albumin dipstick examination in an untimed urine sample. Individuals who tested positive for albuminuria underwent a second dipstick examination after a gap of one week. Individuals with persistent albuminuria on the second dipstick examination underwent further evaluation which included medical history, physical examination, 24 h urine protein estimation, total serum protein and albumin estimation. Ultrasound of the abdomen was done in patients with renal failure and renal biopsy was performed in selected patients. Of the total 5,043 individuals screened, 63.1 per cent were females. Mean age of the study population was 50.94 +/- 11.2 yr. First dipstick test identified 594 individuals positive for albuminuria. Repeat dipstick could be done in only 576, of whom 212 showed persistent albuminuria. Significant proteinuria was detected in 24 individuals of the 208 who had 24 h urine protein measured. Of these 24 patients, 3 were found to have chronic renal failure, 12 were presumed to have diabetic nephropathy clinically, one each had focal segmental glomerulosclerosis and biopsy proven diabetic nephropathy, and 7 patients had proteinuria of unknown aetiology. The prevalence of proteinuria in this adult rural population was 0.47 per cent (0.30-0.67%). The detection and treatment of chronic kidney disease in 24 individuals is bound to reduce the rate of decline of renal functions. Screening programme for proteinuria in different parts of country may be an effective measure to bring a decline in rate of progression of chronic kidney disease in general population.


  • Presentation, prognosis and outcome of IgA nephropathy in Indian adults

    by Bobby Chacko, George T John, Nithya Neelakantan, Anila Korula, Narasimhan Balakrishnan, Meshach G Kirubakaran, Chakko K Jacob

    SUMMARY: Background:  IgA nephropathy (IgAN) is not well characterized in India. This retrospective study of 478 patients with IgAN was performed to clarify the presenting features, prognostic factors and the renal survival rates of the disease.Methods:  Three hundred and forty‐seven patients who had been followed on average for 27 months after diagnosis were divided into two groups based on renal function at diagnosis. In group 1 (229 patients), the creatinine clearance estimated by the Modification of Diet in Renal Disease formula was Results:  The predominant modes of presentation were nephrotic syndrome, hypertension and renal failure. Twenty‐nine percent of patients had more than a 20% decline in renal function at the last follow up. Multivariate analyses with stepwise logistic regression identified hypertension (odds ratio (OR) 3.5), nephrotic range proteinuria (OR 3.4) and sclerosed glomeruli on biopsy (OR 4.1) to be independently associated with progression in group 1 and hypertension (OR 2.3) in group 2. Seventeen percent of patients progressed to end‐stage renal disease (ESRD). Using multivariate analysis by the Cox model, four risk factors for developing ESRD were identified: hypertension (hazard ratio (HR) 3.1); nephrotic proteinuria (HR 1.9); interstitial fibrosis (HR 2.5); and sclerosed glomeruli (HR 1.8). The renal survival rates at 1, 5 and 10 years were 84, 55 and 33%, respectively, with a median renal survival of 61 months from the time of biopsy.Conclusion:  The relatively rapid rate of progression of IgAN in India is suggestive towards a ‘malignant’ nature of the disease in this country.